Why the study?
Does colesevelam hydrochloride improve hyperglycemia and cholesterol levels in patients with type 2 diabetes?
Does colesevelam hydrochloride improve hyperglycemia and cholesterol levels in patients with type 2 diabetes?
Colesevelam hydrochloride offers a dual benefit of glucose and cholesterol lowering for the management of patients with type 2 diabetes.
Answers are grounded in this paper and cite their sources.
May support dual glucose-lipid lowering with colesevelam in T2D; hypothesis-generating and requires RCTs before practice change.
BACKGROUND: At present there are 246 million individuals with diabetes worldwide and this is anticipated to grow to 380 million by 2025. Internationally, the control of glucose and cholesterol to targets is less than optimal in patients with type 2 diabetes. OBJECTIVE: To summarize the chemistry, pharmacokinetics and metabolism of colesevelam hydrochloride, and review its clinical efficacy and toxicity in the management of type 2 diabetes. METHODS: Literature search of colesevelam studies and abstracts assessing the benefits in managing type 2 diabetes mellitus. RESULTS/CONCLUSIONS: Several studies have demonstrated the efficacy of colesevelam hydrochloride in the treatment of hyperglycemia associated with type 2 diabetes. The established dual role of cholesterol lowering and glucose lowering needs to be considered when managing patients with type 2 diabetes.
No takes yet. Share an insight, caveat, or question.
Joel C. Marrs (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: